Developing RNAi-Mediated Therapeutics for Fibrolamellar Carcinoma
Principal Investigator: Praveen Sethupathy
Department of Biomedical Sciences
Email: pr46@cornell.edu
Sponsor: Alnylam Pharmaceuticals Inc.
Title: Developing RNAi-Mediated Therapeutics for Fibrolamellar Carcinoma
Project Amount: $200,000
Project Period: December 2020 to December 2021